239 related articles for article (PubMed ID: 24102057)
1. Pharmacological treatment for hepatopulmonary syndrome.
Eshraghian A; Kamyab AA; Yoon SK
Biomed Res Int; 2013; 2013():670139. PubMed ID: 24102057
[TBL] [Abstract][Full Text] [Related]
2. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD
J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine for hepatopulmonary syndrome?
Altschuler EL; Kast RE
Med Hypotheses; 2004; 62(3):446-7. PubMed ID: 14975520
[TBL] [Abstract][Full Text] [Related]
4. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.
Zhang J; Ling Y; Luo B; Tang L; Ryter SW; Stockard CR; Grizzle WE; Fallon MB
Gastroenterology; 2003 Nov; 125(5):1441-51. PubMed ID: 14598260
[TBL] [Abstract][Full Text] [Related]
6. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment.
Grace JA; Angus PW
J Gastroenterol Hepatol; 2013 Feb; 28(2):213-9. PubMed ID: 23190201
[TBL] [Abstract][Full Text] [Related]
7. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome.
Cremona G; Higenbottam TW; Mayoral V; Alexander G; Demoncheaux E; Borland C; Roe P; Jones GJ
Eur Respir J; 1995 Nov; 8(11):1883-5. PubMed ID: 8620957
[TBL] [Abstract][Full Text] [Related]
8. Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
Suk KT; Kim MY; Jeong SW; Jang JY; Jang YO; Baik SK
Dig Dis Sci; 2018 Jan; 63(1):248-256. PubMed ID: 29192374
[TBL] [Abstract][Full Text] [Related]
9. Review article: Update on current and emergent data on hepatopulmonary syndrome.
Soulaidopoulos S; Cholongitas E; Giannakoulas G; Vlachou M; Goulis I
World J Gastroenterol; 2018 Mar; 24(12):1285-1298. PubMed ID: 29599604
[TBL] [Abstract][Full Text] [Related]
10. A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine.
Yilmaz S; Dursum M; Canoruç F; Bayan K; Karabulut A; Akay H
Neth J Med; 2005 Dec; 63(11):448-52. PubMed ID: 16397315
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of tanshinol on the hepatopulmonary syndrome in rat].
Jia JT; Zhang HY; Lai LN; Li XJ; Tian XX; Zhang LL; Lv ML; Zhao ZF; Han DW; Cheng J
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 May; 30(3):199-203. PubMed ID: 25244780
[TBL] [Abstract][Full Text] [Related]
12. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome.
Brussino L; Bucca C; Morello M; Scappaticci E; Mauro M; Rolla G
Lancet; 2003 Jul; 362(9377):43-4. PubMed ID: 12853200
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1 participates in pulmonary angiogenesis in experimental hepatopulmonary syndrome mice through inhibiting AKT/ERK signaling pathway and regulating NO/NOS release.
Gu HJ; Zuo S; Liu HY; Gu LL; Yang XW; Liao J; Wang QQ; Zhao R; Feng XS; Li HY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6645-6656. PubMed ID: 31378907
[TBL] [Abstract][Full Text] [Related]
14. Hepatopulmonary syndrome: role of nitric oxide and clinical aspects.
Rolla G
Dig Liver Dis; 2004 May; 36(5):303-8. PubMed ID: 15191196
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.
Fallon MB
Ann Intern Med; 2000 Nov; 133(9):738-40. PubMed ID: 11074907
[No Abstract] [Full Text] [Related]
16. Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.
Zhang HY; Han DW; Su AR; Zhang LT; Zhao ZF; Ji JQ; Li BH; Ji C
World J Gastroenterol; 2007 Dec; 13(47):6385-95. PubMed ID: 18081228
[TBL] [Abstract][Full Text] [Related]
17. [Improved oxygenation with nitric oxide treatment for hepatopulmonary syndrome after a liver transplant].
Díaz S; Garutti I; Cruz P; Galán A; Fuentes J; Fernández-Quero L
Rev Esp Anestesiol Reanim; 2001; 48(7):340-3. PubMed ID: 11591283
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis and hepatopulmonary syndrome.
Tumgor G
World J Gastroenterol; 2014 Mar; 20(10):2586-94. PubMed ID: 24627594
[TBL] [Abstract][Full Text] [Related]
19. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
Luo B; Liu L; Tang L; Zhang J; Stockard CR; Grizzle WE; Fallon MB
J Hepatol; 2003 May; 38(5):556-63. PubMed ID: 12713865
[TBL] [Abstract][Full Text] [Related]
20. Hepatopulmonary syndrome - past to present.
Varghese J; Ilias-basha H; Dhanasekaran R; Singh S; Venkataraman J
Ann Hepatol; 2007; 6(3):135-42. PubMed ID: 17786138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
